Browse > Article
http://dx.doi.org/10.3345/kjp.2010.53.1.93

The effect of perioperative inhaled iloprost on congenital heart disease with severe pulmonary arterial hypertension  

Kim, Su Nam (Department of Pediatrics, Gil Hospital, Gachon University of Medicine)
Choi, Deok Young (Department of Pediatrics, Gil Hospital, Gachon University of Medicine)
Publication Information
Clinical and Experimental Pediatrics / v.53, no.1, 2010 , pp. 93-96 More about this Journal
Abstract
A 47-year-old male patient in whom atrial septal defect (ASD) had been diagnosed 15 years previously was admitted for cardiac catheterization. He had definite cyanotic lips and nail beds and severe pulmonary arterial hypertension (PAH). He had received medical treatment only for the last few years after being diagnosed with Eisenmenger syndrome. After cardiac catheterization, he received iloprost inhalation therapy pre and postoperation and was discharged after successful surgical closure of the ASD.
Keywords
Atrial septal defect; Pulmonary arterial hypertension; Iloprost;
Citations & Related Records
Times Cited By KSCI : 3  (Citation Analysis)
연도 인용수 순위
1 Engelfriet P, Meijboom F, Boersma E, Tijssen J, Mulder B. Repaired and open atrial septal defects type II in adulthood: An epidemiological study of a large European cohort. Int J Cardiol 2008;126:379-85   DOI   ScienceOn
2 Engelfriet PM, Duffels MG, Moller T, Boersma E, Tijssen JG, Thaulow E, et al. Pulmonary arterial hypertension in adults born with a heart septal defect: the Euro Heart Survey on adult congenital heart disease. Heart 2007;93:682-7   DOI   PUBMED
3 Lee JE, Hillier SC, Knoderer CA. Use of sildenafil to facilitate weaning from inhaled nitric oxide in chilren with pulmonary hypertension following surgery for congenital heart disease. J Intensive Care Med 2008;23:329-34   DOI   ScienceOn
4 Olschewski H, Rose F, Schermuly R, Ghofrani HA, Enke B, Olschewski A, Seeger W. Prostacyclin and its analogues in the treatment of pulmonary hypertension. Pharmacol Ther 2004;102:139-53   DOI   ScienceOn
5 Kim DK, Kim HK, Lim JA, Jeong SM, Jang SW, Yun IJ. Perioperative combined use of sildenafil and inhaled iloprost for moderate portopulmonary hypertension in a petient undergoing liver trasplantation - A case report-. Korean J Anesthesiol 2008;54:102-8   DOI   ScienceOn
6 Jung JW. Pulmonary arterial hypertension of congenital heart disease: from reversible pulmonary hypertension to Eisenmenger syndrome. Korean Circ J 2007;37:287-97   DOI   ScienceOn
7 Chang WH, Oh TY, Bae SI. Surgical Treatment of Atrial Septal Defect in adult. Korean J Thorac Cardiovasc Surg 1998;31:770-5
8 Kim JH, Lee KC, Chang YJ, Lim YT, Park JC, Cho YL. Inhaled nitric oxide as a therapy for pulmonary hypertension after operation for congenital heart disease. Korean J Anesthesiol 1999;37:1084-8
9 Winterhalter M, Simon A, Fischer S, Rahe-Meyer N, Chamtzidou N, Hecker H, et al. Comparison of inhaled iloprost and nitric oxide in patents with pulmonary hypertension during weaning from cardiopulmonary bypass in cardiac surgery: a prospective randomized trial. J Cardiothorac Vasc Anesth 2008;22:406-13   DOI   ScienceOn
10 Schwerzmann M, Zafar M, McLaughlin PR, Chamberlain DW, Webb G, Granton J. Atrial septal defect closure in a patient with 'irreversible' pulmonary hypertensive arteriopathy. Int J Cardiol 2006;110:104-7   DOI   ScienceOn
11 Frost AE, Quinones MA, Zoghbi WA, Noon GP. Reversal of pulmonary hypertension and subsequent repair of atrial septal defect after treatment with continuous intravenous epoprostenol. J Heart Lung Transplant 2005;24:501-3   DOI   ScienceOn
12 Goldsmith DR, Wagstaff AJ. Inhaled iloprost: in primary pulmonary hypertension. Drugs 2004;64:763-73   DOI   ScienceOn
13 Viswanathan S, Kumar RK. Assessment of operability of congenital cardiac shunts with increased pulmonary vascular resistance. Catheter Cardiovasc Interv 2008;71:665-70   DOI   ScienceOn
14 Bratel T, Laqerstrand L, Brodin LA, Nowak J, Randmaa I. Ventilation/perfusion ratios in pulmonary arterial hypertension: effects of IV and inhaled prostacyclin derivatives. Chest 2005;128:615S-6S   PUBMED
15 Roques F, Nashef P, Michel E. Risk factors and outcome in European cardiac surgery: Analysis of the EuroSCORE multinational database of 19030 patients. Eur J Cardiothorac Surg 1999;15:816-23   DOI   ScienceOn
16 Kim KB, Choi JS. Treatment of pulmonary hypertensive crisis using ECMO. Korean J Thorac Cardiovasc Surg 2002;35:664-7
17 Hoetzenecker K, Ankersmit HJ, Bonderman D, Hoetzenecker W, Seitelberger R, Klepetko W, et al. Atrial septal defect repair after a 10-month treatment with bosentan in a patient with severe pulmonary arterial hypertension: A case report. J Thorac Cardiovasc Surg 2009;137:760-1   DOI   ScienceOn